BPCR.L
BioPharma Credit Ord

— · — · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

1.16B USD

Market Cap

1.09B USD

Margin of Safety

6.0%

Intrinsic / Market Ratio

1.06×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

1.15B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

1.19B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

1.15B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

1.16B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

1.16B USD

from the sum above

Market Cap

1.09B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

1.06×

the ratio the screener ranks by; Margin of Safety +6.0% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 1.15B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).

The earnings power value was not computed (a NOPAT at or below zero this year), so the value is the book value today, 1.15B USD.

Market value

Market Cap1.09B USD

The price on the date above times the shares.

Value vs market

Margin of Safety+5.0%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 1.19B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE968.04M USD
+②Equity at Year 15, Today220.76M USD
=Value1.19B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROE on new investment rising to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

968.04M USD

②Equity at Year 15, Today

220.76M USD

Market value

Market Cap1.09B USD

The price on the date above times the shares.

Value vs market

Margin of Safety+8.0%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 1.15B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (an operating profit at or below zero in the latest three years), so the value is the book value today, 1.15B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap1.09B USD

The price on the date above times the shares.

Value vs market

Margin of Safety+5.0%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 10.50%
Cost of Equity =Risk-Free Rate 4.50%+Beta (default) 1.00×Market Risk Premium 6.00%= 10.50%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC 25.00% (default): the statements print a tax provision of 0 USD on a pretax income of 130.02M USD, which gives no rate between 0 and the profit before tax, so the 25% default stands for the tax the interest saves.

Interest Expense =EBIT —−Pretax Income 130.02M USD= —

The interest the company paid: EBIT is the profit before tax plus the interest.

No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.

Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.

Debt Weight =Total Debt 0 USDMarket Cap + Total Debt 1.09B USD + 0 USD= 0.00%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 100.00%×Cost of Equity 10.50%+Debt Weight 0.00%×Cost of Debt 4.00%= 10.50%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2025-12-31.

Total Assets 1.17B USD − Total Liabilities 17.57M USD = Book Value Today 1.15B USD

Total Debt 0 USD − Cash and Cash Equivalents 12.60M USD = Net Debt Today -12.60M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-13.3%at most 5%passes1,129,227,778 / 1,302,679,192
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets-3.3%at least -10.0%passes(91.19M USD − 130.02M USD) ÷ 1.17B USD
Price to bookMarket Cap ÷ Book Value Today0.95×at most 3×passes1.09B USD ÷ 1.15B USD
Operating marginOperating Income ÷ Revenue—above 10.0%not measured0 USD ÷ 132.19M USD
Revenue growthRevenue ÷ Revenue a Year Before − 16.1%above 10.0%does not pass132.19M USD / 124.58M USD
Net cash(Cash − Total Debt) ÷ Market Cap1.2%above -30%passes(12.60M USD − 0 USD) ÷ 1.09B USD
Operating efficiencyOperating Income ÷ Gross Profit—above 25.0%not measured0 USD ÷ 0 USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

0.97 USD

Enterprise value

—

the provider's own figure

EV / EBITDA

—

Price / book

0.96×

the provider's book

Price / earnings

9.74×

Return on equity

—

the provider's figure, not this page's

Profit margin

—

Revenue growth

—

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

184.43M110.60M124.58M132.19M

Gross profit

————

Operating income

————

EBITDA

operating income before depreciation and amortisation

————

Pretax income

182.49M108.56M122.30M130.02M

Net income

182.49M108.56M122.30M130.02M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

182.49M108.56M122.30M130.02M

R&D

————
Balance sheet, year end

Total assets

1.37B1.36B1.20B1.17B

Total liabilities

26.59M15.89M17.96M17.57M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.34B1.34B1.18B1.15B

Total debt

————

Cash and equivalents

120.65M86.29M5.63M12.60M

Net PP&E

fixed assets after depreciation

————

Working capital

current assets less current liabilities

————
Cash flow

Operating cash flow

184.46M123.31M112.02M91.19M

Capital expenditure

paid out, so below zero

————

Depreciation and amortisation

————

Free cash flow

operating cash flow plus capital expenditure

184.46M123.31M112.02M91.19M